UCSF

ZINC00389747

Substance Information

In ZINC since Heavy atoms Benign functionality
October 31st, 2005 24 Yes

Other Names:

(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one

(-)-Naloxone

(5alpha)-17-Allyl-3,14-dihydroxy-4,5-epoxymorphinan-6-one hydrochloride dihydrate

(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one

(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one

1-N-Allyl-14-hydroxynordihydromorphinone

1-N-Allyl-14-hydroxynordihydromorphinone; 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one; 17-Allyl-4,5alpha

1-N-Allyl-14-hydroxynordihydromorphinone; 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one; Naloxone

1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone

12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone

12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one

17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one

17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one

17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one

3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one

357-08-4 (hydrochloride)

357-08-4; D01340; Naloxone hydrochloride (JP16/USP); Narcan (TN)

357-08-4; Naloxone hydrochloride; Prestwick_879

465-65-6

465-65-6; C07252; Naloxone

465-65-6; D08249; DBL Naloxone (TN); Naloxone (INN)

4aH-8,9c-Iminoethanophenanthro[4,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-

BIDD:GT0110

BPBio1_000136

BRD-A70461345-003-02-2

BRD-K67511046-003-03-7

BRN 1089071

BSPBio_000122

C07252

CHEBI:7459

CHEMBL80

CID5284596

CPD000058766; NALOXONE HYDROCHLORIDE; SAM002703137

D08249

DAP000097

DB01183

DBL Naloxone

DBL Naloxone (TN)

EINECS 207-365-7

EN 1530 Base

EN 1530 Base;L-Naloxone;N-Allylnoroxymorphone;Nalossone [Dcit];Naloxona [INN-Spanish];Naloxonum [INN-Latin]

EN-15304

ethyl 2-(6-(tert-butoxycarbonyl)pyridin-2-yl)acetate

FDA)

HMS2090F20

HSDB 3279

INN); Naloxone HCl (FDA

INN); Naloxone HCl (JAN

INN); Naloxone Hydrochloride (FDA

JAN

l-N-Allyl-14-hydroxynordihydromorphinone

l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone

L-Naloxone

LS-187184

LS-92141

MFCD00069322

MFCD00150901

MFCD00242634

MolPort-002-536-640

Morphinan-6-one, 17-allyl-4,5.alpha.-epoxy-3,14-dihydroxy-

Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-

Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)

Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-

Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-

Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-

Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)

Morphinan-6-one, 4,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-

Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-

N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon

N-Allyl-noroxymorphone

N-Allylnoroxymorphone

N/A

nal-

Nalone

Nalossone

Nalossone [Dcit]

Naloxon

Naloxona

Naloxona [INN-Spanish]

naloxona; naloxone; naloxonum

Naloxone

Naloxone (BAN

Naloxone (INN)

Naloxone HCl

Naloxone hydrochloride dihydrate

Naloxone hydrochloride dihydrate, 98%+

Naloxone [INN:BAN]

Naloxonum

Naloxonum [INN-Latin]

Narcan

Narcanti

Narcon

Narcon; Narcan; Nalone; Naloxone; l-Naloxone; EN 1530 base; (-)-Naloxone; n-Allylnoroxymorphone; Normorphinone, N-allyl-dihydro-14-hydroxy-; Morphinan-6-one, 4,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-; 4aH-8,9c-Iminoethanophenanthro[4,5-bcd]furan-5(

NCGC00024674-02

Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-

Normorphinone, N-allyl-dihydro-14-hydroxy-

NSC 70413

NSC70413

PDSP2_001520

Prestwick0_000111

Prestwick1_000111

Prestwick2_000111

Prestwick3_000111

SMP1_000205

SPBio_002061

STOCK1N-69923

UNII-36B82AMQ7N

USAN

USP

USP)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.12 3.75 -57.02 3 5 1 71 328.388 2
Hi High (pH 8-9.5) 1.12 1.61 -13.48 2 5 0 70 327.38 2

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 5.64e+00 g/l DrugBank-approved
UniProt Database Links CXAG_NAJAT; MORA_PSEPU; NXSM1_DENPO; NXSM2_DENPO; PA2H_GLOUS ChEBI
PUBCHEM_PATENT_ID EP0144341A1; EP0170090A1; EP0238507A1; EP0250796A2; US4089855; US4496570; US4619936; US4668685; US4673679; US4722928; US4760069; US4912109; US4916142; US4954506; US4990617; US5071985; US5760044; US5866154; US5965567; WO1999003347A1 IBM Patent Data
Patent Database Links EP1535615; EP1557179; EP1584335; EP1600160; EP1604666; EP1604667; EP1639997; EP1681057; EP1685839; EP1695700; EP1702627; EP1767221; EP1785145; EP1813276; EP1813283; EP1815846; EP1820805; EP1829527; EP1829528; EP1849460; EP1870096; EP1894562; EP1897543; EP ChEBI
Therapy narcotic antagonist SMDC MicroSource
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : MZ-3032; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Opioid Receptor Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: MZ-3032; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AA3R-1-E Adenosine Receptor A3 (cluster #1 Of 6), Eukaryotic Eukaryotes 2 0.51 Binding ≤ 10μM
CCR5-1-E C-C Chemokine Receptor Type 5 (cluster #1 Of 4), Eukaryotic Eukaryotes 21 0.45 Binding ≤ 10μM
OPRD-1-E Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 76 0.42 Binding ≤ 10μM
OPRK-1-E Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic Eukaryotes 9 0.47 Binding ≤ 10μM
OPRM-1-E Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 23 0.45 Binding ≤ 10μM
SGMR1-1-E Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic Eukaryotes 44 0.43 Binding ≤ 10μM
OPRK-1-E Kappa Opioid Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 7 0.48 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 5), Other Other 6 0.48 Binding ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 10 0.47 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
AA3R_HUMAN P33765 Adenosine A3 Receptor, Human 1.6 0.51 Binding ≤ 1μM
CCR5_MOUSE P51682 C-C Chemokine Receptor Type 5, Mouse 10.5 0.47 Binding ≤ 1μM
OPRD_HUMAN P41143 Delta Opioid Receptor, Human 120 0.40 Binding ≤ 1μM
OPRD_RAT P33533 Delta Opioid Receptor, Rat 0.1 0.58 Binding ≤ 1μM
OPRK_HUMAN P41145 Kappa Opioid Receptor, Human 0.25 0.56 Binding ≤ 1μM
OPRK_CAVPO P41144 Kappa Opioid Receptor, Guinea Pig 12 0.46 Binding ≤ 1μM
OPRK_RAT P34975 Kappa Opioid Receptor, Rat 0.1 0.58 Binding ≤ 1μM
OPRM_CAVPO P97266 Mu Opioid Receptor, Guinea Pig 0.68 0.53 Binding ≤ 1μM
OPRM_BOVIN P79350 Mu Opioid Receptor, Bovin 5 0.48 Binding ≤ 1μM
OPRM_HUMAN P35372 Mu Opioid Receptor, Human 0.23 0.56 Binding ≤ 1μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 0.1 0.58 Binding ≤ 1μM
Z50597 Z50597 Rattus Norvegicus 42 0.43 Binding ≤ 1μM
SGMR1_RAT Q9R0C9 Sigma Opioid Receptor, Rat 0.1 0.58 Binding ≤ 1μM
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 23 0.45 Binding ≤ 1μM
AA3R_HUMAN P33765 Adenosine A3 Receptor, Human 1.6 0.51 Binding ≤ 10μM
CCR5_MOUSE P51682 C-C Chemokine Receptor Type 5, Mouse 10.5 0.47 Binding ≤ 10μM
OPRD_RAT P33533 Delta Opioid Receptor, Rat 0.1 0.58 Binding ≤ 10μM
OPRD_HUMAN P41143 Delta Opioid Receptor, Human 120 0.40 Binding ≤ 10μM
OPRK_HUMAN P41145 Kappa Opioid Receptor, Human 0.25 0.56 Binding ≤ 10μM
OPRK_CAVPO P41144 Kappa Opioid Receptor, Guinea Pig 12 0.46 Binding ≤ 10μM
OPRK_RAT P34975 Kappa Opioid Receptor, Rat 0.1 0.58 Binding ≤ 10μM
OPRM_RAT P33535 Mu Opioid Receptor, Rat 0.1 0.58 Binding ≤ 10μM
OPRM_CAVPO P97266 Mu Opioid Receptor, Guinea Pig 0.68 0.53 Binding ≤ 10μM
OPRM_BOVIN P79350 Mu Opioid Receptor, Bovin 5 0.48 Binding ≤ 10μM
OPRM_HUMAN P35372 Mu Opioid Receptor, Human 0.23 0.56 Binding ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 42 0.43 Binding ≤ 10μM
SGMR1_RAT Q9R0C9 Sigma Opioid Receptor, Rat 0.1 0.58 Binding ≤ 10μM
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 23 0.45 Binding ≤ 10μM
OPRK_HUMAN P41145 Kappa Opioid Receptor, Human 6.6 0.48 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 10 0.47 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Adenosine P1 receptors
Beta defensins
Chemokine receptors bind chemokines
G alpha (i) signalling events
G-protein activation
Opioid Signalling
Peptide ligand-binding receptors

Analogs ( Draw Identity 99% 90% 80% 70% )